Yuanjian Fang
Overview
Explore the profile of Yuanjian Fang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
943
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen T, Chen J, Guo M, Liu Y, Wang J, Fang Y, et al.
Neuropharmacology
. 2025 Feb;
269:110336.
PMID: 39947392
Background And Purpose: ST2, a member of the interleukin-1 (IL-1) receptor family, along with its ligand IL-33, plays critical roles in immune regulation and inflammatory responses. This study investigates the...
2.
Yu X, Fang Y, Luo Z, Guo X, Fu L, Fan Z, et al.
J Am Chem Soc
. 2025 Jan;
147(2):2193-2205.
PMID: 39752277
Polymer nanoparticles with low curvature, especially two-dimensional (2D) soft materials, are rich in functions and outstanding properties and have received extensive attention. Crystallization-driven self-assembly (CDSA) of linear semicrystalline block copolymers...
3.
Zhang H, Yu Q, Ying C, Liu Y, Wang X, Guo Y, et al.
Saudi Dent J
. 2024 Dec;
36(11):1389-1396.
PMID: 39619717
Introduction: This study aimed to analyze the existing evidence on the association between dental diseases and stroke. Various pathogenic mechanisms, including bacteraemia and systemic inflammation, were investigated to explore their...
4.
Qian Y, Wang J, Chen J, Lin W, Shen H, Fang Y, et al.
Exp Neurol
. 2024 Nov;
383:115036.
PMID: 39486608
Subarachnoid hemorrhage (SAH) is a severe neurological condition characterized by high morbidity and mortality. The unfavorable prognosis of SAH is closely associated with early brain injury (EBI) and delayed cerebral...
5.
Shi H, Fang Y, Huang L, Gao L, Lenahan C, Okada T, et al.
Neurotherapeutics
. 2024 Oct;
21(6):e00468.
PMID: 39419637
No abstract available.
6.
Fang Y, Liu Y, Chen L, Wang J, Zhang J, Zhang H, et al.
J Neuroinflammation
. 2024 Sep;
21(1):237.
PMID: 39334416
Background: Early severe cerebral edema and chronic hydrocephalus are the primary cause of poor prognosis in patients with subarachnoid hemorrhage (SAH). This study investigated the role of cerebrospinal fluid (CSF)...
7.
Xu P, Liu Y, Wang J, Zhang A, Wang K, Wang Z, et al.
CNS Neurosci Ther
. 2024 Aug;
30(8):e14894.
PMID: 39107957
Background: Subarachnoid hemorrhage (SAH) represents a severe stroke subtype. Our study aims to develop gender-specific prognostic prediction models derived from distinct prognostic factors observed among different-gender patients. Methods: Inclusion comprised...
8.
Shi H, Fang Y, Huang L, Gao L, Lenahan C, Okada T, et al.
Neurotherapeutics
. 2024 Apr;
21(3):e00358.
PMID: 38641459
No abstract available.
9.
Zhang H, Xu L, He Y, Zhang Z, Zhang J, Yu Q, et al.
Neuropharmacology
. 2024 Mar;
251:109905.
PMID: 38521229
Oxidative stress plays important roles in the pathogenesis of early brain injury (EBI) after subarachnoid hemorrhage (SAH). Tat-NR2B9c has shown efficacy as a neuroprotective agent in several studies. Here, we...
10.
Fang Y, Shao A, Huang L, Zhang X, Hermann D
Front Cell Neurosci
. 2024 Mar;
18:1384276.
PMID: 38481631
No abstract available.